We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$18.3B
AUM Growth
+$1.38B
Cap. Flow
-$639M
Cap. Flow %
-3.49%
Top 10 Hldgs %
37.51%
Holding
256
New
14
Increased
34
Reduced
47
Closed
63

Sector Composition

Rank Sector Weight
1 Healthcare 33.33%
2 Technology 18.46%
3 Financials 12.48%
4 Industrials 7.09%
5 Communication Services 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSTD
126
DELISTED
Northern Star Investment Corp. IV
NSTD
$1.01M 0.01%
100,000
OKLO
127
Oklo
OKLO
$8.42B
$998K 0.01%
98,300
AMRS
128
DELISTED
Amyris Inc.
AMRS
$961K 0.01%
706,700
-293,300
-29% -$419K
SMC
129
Summit Midstream
SMC
$419M
$894K ﹤0.01%
58,214
+15,159
+35% +$257K
LEGN icon
130
Legend Biotech
LEGN
$4.01B
$849K ﹤0.01%
17,600
-729,014
-98% -$35.7M
CLVR
131
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$736K ﹤0.01%
64,265
-24,687
-28% -$304K
MTAL.WS
132
DELISTED
Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share
MTAL.WS
$602K ﹤0.01%
825,000
LUNRW
133
DELISTED
Intuitive Machines, Inc. Warrants
LUNRW
$532K ﹤0.01%
950,000
BTTX
134
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$509K ﹤0.01%
699,042
-114,514
-14% -$135K
EDU icon
135
New Oriental
EDU
$8.98B
$502K ﹤0.01%
13,000
GRND.WS
136
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
$481K ﹤0.01%
540,000
KRTX
137
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$400K ﹤0.01%
2,200
GATEW
138
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
$223K ﹤0.01%
1,485,000
SLDPW icon
139
Solid Power Inc Warrant
SLDPW
$10.6M
$178K ﹤0.01%
405,316
AAC.WS
140
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$176K ﹤0.01%
200,000
SEDA.WS
141
DELISTED
SDCL EDGE Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A ordinary share at an exercise price of $11.50
SEDA.WS
$175K ﹤0.01%
866,250
KCGI.WS
142
DELISTED
Kensington Capital Acquisition Corp. V Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
KCGI.WS
$145K ﹤0.01%
581,400
IVCPW
143
DELISTED
Swiftmerge Acquisition Corp. Warrants
IVCPW
$124K ﹤0.01%
990,000
NETC.WS
144
DELISTED
Nabors Energy Transition Corp. Warrants, exercisable for one share of Class A Common Stock
NETC.WS
$92.5K ﹤0.01%
450,000
SCRMW
145
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$78.3K ﹤0.01%
333,330
FRXB.WS
146
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$49.6K ﹤0.01%
250,000
CORS.WS
147
DELISTED
Corsair Partnering Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CORS.WS
$47.9K ﹤0.01%
233,330
DISAW
148
DELISTED
Disruptive Acquisition Corporation I Warrant
DISAW
$42K ﹤0.01%
466,667
UTAAW
149
DELISTED
UTA Acquisition Corporation Warrants
UTAAW
$42K ﹤0.01%
175,000
PSPC.WS
150
DELISTED
Post Holdings Partnering Corporation Redeemable Warrants, each whole warrant exercisable for one share of Series A common stock at an exercise price of $11.50
PSPC.WS
$40K ﹤0.01%
266,666

Similar funds

Farallon Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Farallon Capital Management held 256 positions worth $18.3B, up 8.2% from $16.9B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Farallon Capital Management withdrew a net $639M in Q1 2023, closing 63 positions and reducing 47 holdings. Its most notable exit was AbbVie, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in UnitedHealth worth $409M.

  • Farallon Capital Management's largest Q1 2023 buy was UnitedHealth: 866,000 shares worth $409M.
  • Farallon Capital Management added most to Alphabet (Google) Class C in Q1 2023, an estimated $235M increase.
  • Farallon Capital Management's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $87M.
  • Farallon Capital Management fully exited AbbVie in Q1 2023, selling an estimated $152M.
  • Farallon Capital Management's ten largest holdings make up 38% of its $18.3B portfolio in Q1 2023.
  • Farallon Capital Management opened 14 new positions and closed 63 in Q1 2023.
  • Farallon Capital Management's portfolio value rose 8.2% quarter-over-quarter to $18.3B.

Based on Farallon Capital Management's 13F filing for Q1 2023, filed 15 May 2023.